Anastasiia Danishevich, Airat Bilyalov, Sergey Nikolaev, Nodirbec Khalikov, Daria Isaeva, Yuliya Levina, Maria Makarova, Marina Nemtsova, Denis Chernevskiy, Olesya Sagaydak, Elena Baranova, Maria Vorontsova, Mariya Byakhova, Anna Semenova, Vsevolod Galkin, Igor Khatkov, Saida Gadzhieva, Natalia Bodunova
Malignant neoplasms, including pancreatic cancer and melanoma, are major global health challenges. This study investigates melanoma pancreatic syndrome, a rare hereditary tumor syndrome associated with CDKN2A gene mutations. CDKN2A mutations contribute to a lifetime risk of melanoma ranging from 28% to 67%. This study reports the clinical features of six individuals with CDKN2A mutations and identifies recurrent alterations such as c.307_308del, c.159G>C and c.71G>C. It highlights the need for CDKN2A mutation testing in suspected cases of familial atypical multiple mole melanoma...
December 18, 2023: Biomedicines